AstraZeneca pauses coronavirus vaccine trial, shares slip on rollout doubts
- AstraZeneca said on Tuesday it voluntarily paused trials, including late-stage ones, after an illness in a participant
- It was working to expedite the review to minimize any potential impact on the trial timeline
